Literature DB >> 21279243

Construction and use of a library of bona fide heparins employing 1H NMR and multivariate analysis.

Timothy R Rudd1, Davide Gaudesi, Mark A Skidmore, Monica Ferro, Marco Guerrini, Barbara Mulloy, Giangiacomo Torri, Edwin A Yates.   

Abstract

In contrast to most pharmaceutical agents, the major anticoagulant agent, heparin, lacks a uniquely defined chemical structure. It is an inherently structurally varying, poly-disperse polymer, rendering quality control problematic. Structural modifications introduced during manufacture and the presence of possible contaminants are dangers. The comparison of any heparin test sample to a library of bona fide, but intrinsically variable heparins, is limited fundamentally to measuring the degree of similarity between them. A general approach for constructing a suitable illustrative heparin library employing (1)H NMR and multivariate analysis, is proposed and examples shown. Heparin samples contaminated with non-N-acetylated, persulfated, non-glycosaminoglycan carbohydrates (10%) were detected, some of which would not be easily detected under current regulatory guidelines. The ability to identify contaminated heparin is fundamentally dependent on the contents of the library, which should contain all the 'normal' variability within 'heparin'. Oversulfated chondroitin sulfate can be detected (∼5%) (using components 1 and 2, but is detectable at 3% using additional components, e.g. 1 and 5) analysing the full spectrum and at <1% if only the N-acetyl region is used. Signals arising from oxidation during the manufacturing processes can also be found. The design, properties and limitations of this approach are discussed. Assembly of such a library of market heparin can be termed the 'Current Statistical Definition of Heparin' (CSDH) and will form the basis of future quantitative methods. © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21279243     DOI: 10.1039/c0an00834f

Source DB:  PubMed          Journal:  Analyst        ISSN: 0003-2654            Impact factor:   4.616


  3 in total

Review 1.  Recent advances in biotechnology for heparin and heparan sulfate analysis.

Authors:  Meng Qiao; Lei Lin; Ke Xia; Jun Li; Xing Zhang; Robert J Linhardt
Journal:  Talanta       Date:  2020-06-14       Impact factor: 6.057

Review 2.  Tools for the Quality Control of Pharmaceutical Heparin.

Authors:  Anthony Devlin; Courtney Mycroft-West; Patricia Procter; Lynsay Cooper; Scott Guimond; Marcelo Lima; Edwin Yates; Mark Skidmore
Journal:  Medicina (Kaunas)       Date:  2019-09-25       Impact factor: 2.430

3.  SAX-HPLC and HSQC NMR Spectroscopy: Orthogonal Methods for Characterizing Heparin Batches Composition.

Authors:  Franco Spelta; Lino Liverani; Alessandra Peluso; Maria Marinozzi; Elena Urso; Marco Guerrini; Annamaria Naggi
Journal:  Front Med (Lausanne)       Date:  2019-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.